PBYI vs AMGN: Which Stock is Better?
Side-by-side comparison of Puma Biotechnology Inc and Amgen Inc in 2026
PBYI
Puma Biotechnology Inc
—
AMGN
Amgen Inc
$366.44
Key Metrics Comparison
| Metric | PBYI | AMGN | Winner |
|---|---|---|---|
| Market Cap | $165.29M | $188.67B | AMGN |
| P/E Ratio | 4.27 | 24.33 | PBYI |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze PBYI
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PBYI or AMGN a better investment?
Comparing PBYI and AMGN: Puma Biotechnology Inc has a market cap of $165.29M while Amgen Inc has $188.67B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PBYI and AMGN?
PBYI (Puma Biotechnology Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PBYI or AMGN?
Based on P/E ratios, PBYI trades at a lower multiple (4.3x vs 24.3x).
Which is growing faster: PBYI or AMGN?
Both PBYI and AMGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: PBYI or AMGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: PBYI or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $188.67B compared to $165.29M for PBYI.
Should I buy PBYI or AMGN in 2026?
Both PBYI and AMGN have investment merit. PBYI trades at $N/A while AMGN trades at $366.44. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PBYI and AMGN stock?
Key differences: Market Cap ($165.29M vs $188.67B), P/E Ratio (4.3x vs 24.3x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy PBYI or AMGN in 2026?
The choice between PBYI and AMGN depends on your investment goals. AMGN shows higher revenue growth (0.0%). AMGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PBYI and AMGN?
PBYI (Puma Biotechnology Inc) has a market cap of $165.29M, while AMGN (Amgen Inc) has a market cap of $188.67B. AMGN is the larger company by market value.